干旱区生态环境知识资源中心(Arid): The OaSiS trial: A hybrid type II, national cluster randomized trial to implement smoking cessation during CT screening for lung cancer

Arid

DOI	10.1016/j.cct.2020.105963
	The OaSiS trial: A hybrid type II, national cluster randomized trial to implement smoking cessation during CT screening for lung cancer
	Foley, Kristie Long 1; Miller, David P., Jr.1,2; Weaver, Kathryn 1,3; Sutfin, Erin L.3; Petty, W. Jeffrey 4; Bellinger, Christina 5; Spangler, John 6; Stone, Rebecca J.1; Lawler, Donna 1; Davis, Whitney 1; Dressler, Emily 7; Lesser, Glenn 2,4; Chiles, Caroline 8
通讯作者	Foley, Kristie Long
来源期刊	CONTEMPORARY CLINICAL TRIALS
ISSN	1551-7144
EISSN	1559-2030
出版年	2020
卷号	91
英文摘要	Introduction: When the Centers for Medicare and Medicaid Services announced coverage for low dose CT lung cancer screening, they also mandated that imaging centers offer smoking cessation services. We designed the Optimizing Lung Screening (OaSiS) trial to evaluate strategies to implement the Public Health Service Guidelines for Treating Tobacco Use and Dependence during CT screening for lung cancer. Methods and design: OaSiS was implemented using a pragmatic effectiveness-implementation hybrid design in 26 imaging clinics across the United States affiliated with the National Cancer Institute's National Community Oncology Research Program (NCORP). The 26 sites selected for participation in the OaSiS trial were randomized to receive either a compendium of implementation strategies to add or enhance smoking cessation services during lung screening or to usual care. Usual care sites were given the option to receive the full compendium of implementation strategies at the conclusion of data collection. We have evaluated both the effectiveness of the implementation strategies to improve smoking cessation at six months among patients undergoing LDCT screening as well as the adoption and sustainability of evidence-based tobacco cessation strategies in imaging clinics. Discussion: The OaSiS trial was designed to identify opportunities for implementing evidence-based smoking cessation into LDCT lung cancer screening imaging facilities and to establish the effectiveness of these services. We report our study design and evaluation, including strengths of the pragmatic design and the inclusion of a diverse range of screening programs. Establishing these tobacco cessation services will be critical to reducing smoking related morbidity and mortality.
英文关键词	Tobacco cessation Lung cancer screening PHS guidelines Low dose computed tomography Smoking cessation NCORP
类型	Article
语种	英语
国家	USA
开放获取类型	Green Accepted
收录类别	SCI-E ; SSCI
WOS记录号	WOS:000537083100006
WOS关键词	TOBACCO-CESSATION ; COST-EFFECTIVENESS ; INTERVENTIONS
WOS类目	Medicine, Research & Experimental ; Pharmacology & Pharmacy
WOS研究方向	Research & Experimental Medicine ; Pharmacology & Pharmacy
资源类型	期刊论文
条目标识符	http://119.78.100.177/qdio/handle/2XILL650/318959
作者单位	1.Wake Forest Sch Med, Dept Implementat Sci, Med Ctr Blvd, Winston Salem, NC 27157 USA; 2.Internal Med, Med Ctr Blvd, Winston Salem, NC 27157 USA; 3.Social Sci & Hlth Policy, Med Ctr Blvd, Winston Salem, NC 27157 USA; 4.Hematol & Oncol, Med Ctr Blvd, Winston Salem, NC 27157 USA; 5.Pulmonol & Crit Care, Med Ctr Blvd, Winston Salem, NC 27157 USA; 6.Family & Community Med, Med Ctr Blvd, Winston Salem, NC 27157 USA; 7.Biostat & Data Sci, Med Ctr Blvd, Winston Salem, NC 27157 USA; 8.Radiol, Med Ctr Blvd, Winston Salem, NC 27157 USA
推荐引用方式 GB/T 7714	Foley, Kristie Long,Miller, David P., Jr.,Weaver, Kathryn,et al. The OaSiS trial: A hybrid type II, national cluster randomized trial to implement smoking cessation during CT screening for lung cancer[J],2020,91.
APA	Foley, Kristie Long.,Miller, David P., Jr..,Weaver, Kathryn.,Sutfin, Erin L..,Petty, W. Jeffrey.,...&Chiles, Caroline.(2020).The OaSiS trial: A hybrid type II, national cluster randomized trial to implement smoking cessation during CT screening for lung cancer.CONTEMPORARY CLINICAL TRIALS,91.
MLA	Foley, Kristie Long,et al."The OaSiS trial: A hybrid type II, national cluster randomized trial to implement smoking cessation during CT screening for lung cancer".CONTEMPORARY CLINICAL TRIALS 91(2020).